For example, the CCL5 -28 CG/GG single nucleotide promoter polymorphism has been associated with increased risk of developing SARS and SARS mortality in a gene dosage-dependent manner (Ng et al., 2007; Lau and Peiris, 2009). This evidence concerns the gene CCL5 and severe acute respiratory syndrome.